Circulating small extracellular vesicles mediate vascular hyperpermeability in diabetes
Open Access
- 15 March 2024
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 67 (6) , 1138-1154
Abstract
Aims/hypothesis: A hallmark chronic complication of type 2 diabetes mellitus is vascular hyperpermeability, which encompasses dysfunction of the cerebrovascular endothelium and the subsequent development of associated cognitive impairment. The present study tested the hypothesis that during type 2 diabetes circulating small extracellular vesicles (sEVs) exhibit phenotypic changes that facilitate pathogenic disruption of the vascular barrier. Methods: sEVs isolated from the plasma of a mouse model of type 2 diabetes and from diabetic human individuals were characterised for their ability to disrupt the endothelial cell (EC) barrier. The contents of sEVs and their effect on recipient ECs were assessed by proteomics and identified pathways were functionally interrogated with small molecule inhibitors. Results: Using intravital imaging, we found that diabetic mice (Leprdb/db) displayed hyperpermeability of the cerebrovasculature. Enhanced vascular leakiness was recapitulated following i.v. injection of sEVs from diabetic mice into non-diabetic recipient mice. Characterisation of circulating sEV populations from the plasma of diabetic mice and humans demonstrated increased quantity and size of sEVs compared with those isolated from non-diabetic counterparts. Functional experiments revealed that sEVs from diabetic mice or humans induced the rapid and sustained disruption of the EC barrier through enhanced paracellular and transcellular leak but did not induce inflammation. Subsequent sEV proteome and recipient EC phospho-proteome analysis suggested that extracellular vesicles (sEVs) from diabetic mice and humans modulate the MAPK/MAPK kinase (MEK) and Rho-associated protein kinase (ROCK) pathways, cell–cell junctions and actin dynamics. This was confirmed experimentally. Treatment of sEVs with proteinase K or pre-treatment of recipient cells with MEK or ROCK inhibitors reduced the hyperpermeability-inducing effects of circulating sEVs in the diabetic state. Conclusions/interpretation: Diabetes is associated with marked increases in the concentration and size of circulating sEVs. The modulation of sEV-associated proteins under diabetic conditions can induce vascular leak through activation of the MEK/ROCK pathway. These data identify a new paradigm by which diabetes can induce hyperpermeability and dysfunction of the cerebrovasculature and may implicate sEVs in the pathogenesis of cognitive decline during type 2 diabetes. GraphicalKeywords
Funding Information
- Canadian Vascular Network
- Canadian Institutes of Health Research (PJT148487, PJT173489)
- Canadian Cancer Society (702835)
This publication has 48 references indexed in Scilit:
- MIBlood‐EV: Minimal information to enhance the quality and reproducibility of blood extracellular vesicle researchJournal of Extracellular Vesicles, 2023
- Permeability of the Endothelial Barrier: Identifying and Reconciling ControversiesTrends in Molecular Medicine, 2021
- Single-Cell Transcriptome Atlas of Murine Endothelial CellsCell, 2020
- What is the blood concentration of extracellular vesicles? Implications for the use of extracellular vesicles as blood-borne biomarkers of cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2019
- Molecular and functional characterization of circulating extracellular vesicles from diabetic patients with and without retinopathy and healthy subjectsExperimental Eye Research, 2018
- An Endothelial-to-Adipocyte Extracellular Vesicle Axis Governed by Metabolic StateCell, 2018
- Hyperglycemia-Driven Neuroinflammation Compromises BBB Leading to Memory Loss in Both Diabetes Mellitus (DM) Type 1 and Type 2 Mouse ModelsMolecular Neurobiology, 2018
- Stepwise Recruitment of Transcellular and Paracellular Pathways Underlies Blood-Brain Barrier Breakdown in StrokeNeuron, 2014
- World Medical Association Declaration of HelsinkiJAMA, 2013
- The Family Investigation of Nephropathy and Diabetes (FIND)Journal of Diabetes and its Complications, 2005